MARLENE DEBEL - 13 Dec 2024 Form 4 Insider Report for METLIFE INC (MET)

Signature
/s/ Taylor Jansen, Authorized Signer
Issuer symbol
MET
Transactions as of
13 Dec 2024
Net transactions value
-$995,149
Form type
4
Filing time
17 Dec 2024, 16:20:32 UTC
Previous filing
05 Mar 2024
Next filing
24 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Options Exercise $449,963 +13,107 +12% $34.33 121,614 13 Dec 2024 Direct
transaction MET Common Stock Options Exercise $445,465 +9,703 +8% $45.91 131,317 13 Dec 2024 Direct
transaction MET Common Stock Sale $1,890,577 -22,810 -17% $82.88 108,507 13 Dec 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MET Employee Stock Options (right to buy) Options Exercise $0 -13,107 -100% $0.000000 0 13 Dec 2024 Common Stock 13,107 $34.33 Direct F2
transaction MET Employee Stock Options (right to buy) Options Exercise $0 -9,703 -100% $0.000000 0 13 Dec 2024 Common Stock 9,703 $45.91 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $82.83 to $82.931, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
F2 The options became exercisable in three substantially equal installments on February 23, 2017, 2018, and 2019.
F3 The options became exercisable in three substantially equal installments on February 24, 2016, February 24, 2017, and February 27, 2018.